|4Jan 21, 7:29 PM ET

Atillasoy Ercem 4

4 · Allovir, Inc. · Filed Jan 21, 2021

Insider Transaction Report

Form 4
Period: 2021-01-19
Atillasoy Ercem
See Remarks
Transactions
  • Award

    Common Stock

    2021-01-19+28,000106,500 total
  • Award

    Stock Option (Right to Buy)

    2021-01-19+52,00052,000 total
    Exercise: $42.15Exp: 2031-01-19Common Stock (52,000 underlying)
Footnotes (2)
  • [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on January 19, 2022, with the remainder vesting in twelve equal quarterly installments thereafter.
  • [F2]25% of this option shall vest and become exercisable on January 19, 2022, with the remainder vesting in twelve equal quarterly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION